Your browser doesn't support javascript.
loading
A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
Talbot, P R; Lloyd, J J; Snowden, J S; Neary, D; Testa, H J.
Affiliation
  • Talbot PR; Department of Neurology, Manchester Royal Infirmary, UK.
J Neurol Neurosurg Psychiatry ; 64(3): 306-13, 1998 Mar.
Article in En | MEDLINE | ID: mdl-9527139
ABSTRACT

OBJECTIVES:

To provide the clinician with a guide to the clinical utility of 99mTc-HMPAO single photon emission computed tomography (SPECT) and to the interpretation of specific test results in the differential diagnosis of dementia.

METHODS:

Three hundred and sixty three patients with dementia were studied prospectively for a median three (range 1-6) years and classified into disease groups on the basis of established clinical criteria. The degree to which different patterns of cerebral blood flow (CBF) abnormality found on 99mTc-HMPAO SPECT imaging at the time of initial patient presentation modified clinical diagnoses was determined by calculating the likelihood ratios for pairwise disease group comparisons. The optimal clinical usage of 99mTc-HMPAO SPECT was determined by calculating the percentage of significant test results for each pairwise disease group comparison.

RESULTS:

Bilateral posterior CBF abnormality was found to significantly increase the odds of a patient having Alzheimer's disease as opposed to vascular dementia or frontotemporal dementia. Bilateral anterior CBF abnormality significantly increased the odds of a patient having frontotemporal dementia as opposed to Alzheimer's disease, vascular dementia, or Lewy body disease. "Patchy" CBF changes significantly increased the odds of a patient having vascular dementia as opposed to Alzheimer's disease. Unilateral anterior, unilateral anterior plus unilateral posterior, and generalised CBF abnormality failed to contribute to the differentiation of any of these forms of dementia.

CONCLUSIONS:

99mTc-HMPAO SPECT was found to be most useful in distinguishing Alzheimer's disease from vascular dementia and fronto temporal dementia, and least useful in differentiating between Alzheimer's disease and Lewy body disease, and between vascular dementia, frontotemporal dementia, and progressive aphasia. It is suggested that CBF SPECT should be used selectively and as an adjunct to clinical evaluation and CT.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tomography, Emission-Computed, Single-Photon / Technetium Tc 99m Exametazime / Dementia Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Neurosurg Psychiatry Year: 1998 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tomography, Emission-Computed, Single-Photon / Technetium Tc 99m Exametazime / Dementia Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Neurosurg Psychiatry Year: 1998 Document type: Article Affiliation country: Reino Unido
...